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Abstract 9 
Background 10 
Little is known about the extent to which routine care management of peripheral arterial disease 11 
and intermittent claudication align with best practice recommendation on exercise therapy. We 12 
conducted a scoping review to examine the published literature on availability and workings 13 
of exercise therapy in routine management of patients with peripheral arterial disease and 14 
intermittent claudication, and health professional and patients’ attitude and practice.   15 
Data sources 16 
The Cumulative Index of Nursing and Allied Health Literature, Ovid MEDLINE, Allied and 17 
Complementary Medicine Database, ScienceDirect, Web of Science and the Directory of Open 18 
Access Repositories were searched. Hand searching of reference lists of identified studies was 19 
also performed.   20 
Methods 21 
A systematic search was conducted in February 2018. Inclusion criteria were based on study 22 
aim, and included studies that reported on perceptions, practices, and workings of routine 23 
exercise programs for patients with intermittent claudication, their availability, access and 24 
perceived barriers.  25 
Results 26 
Eight studies met the eligibility criteria and were included in the review. Included studies were 27 
studies conducted within Europe. Findings indicate that vascular surgeons in parts of Europe 28 
generally recognize supervised exercise therapy as a best practice treatment for intermittent 29 
claudication, but do not often refer their patients for supervised exercise therapy due to the 30 
unavailability of, or lack of access to supervised exercise therapy programs. Available 31 
supervised exercise therapy programs do not implement best practice recommendations, and 32 
in the majority, patients only undergo one session per week. Some challenges were cited as the 33 
cause of the sub-optimal program implementation. These included issues related to patients’ 34 
engagement and adherence as well as resource constraints.  35 
Conclusion 36 
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There is dearth of published research on exercise therapy in routine management of peripheral 1 
arterial disease and intermittent claudication. Available data from few countries within the 2 
Europe indicate that supervised exercise is an underutilized despite health professionals 3 
recognizing the benefits. Research is needed to understand how to improve the availability, 4 
access, uptake and adherence to the best exercise recommendations in routine management of 5 
people with peripheral arterial disease and intermittent claudication.  6 
 7 
 8 
INTRODUCTION 9 
The most common symptom of peripheral arterial disease (PAD) is intermittent claudication 10 
(IC)1 defined as exertional pain in the lower limb(s) which is relieved by rest. Intermittent 11 
claudication limits individuals’ exercise capacity, decreases functional ability and leads to 12 
poorer quality of life. 2–4 Individuals with PAD and IC have lower levels of physical activity 13 
compared with their age-matched healthy controls.5,6 Exercise therapy is the most effective 14 
conservative therapy for improving walking capacity in people with IC.7,89–11 Exercise  therapy 15 
is an important area of research in PAD and IC care internationally, and is recommended by 16 
several professional guidelines.7,12–14 Although both supervised and unsupervised exercise 17 
programs improve pain-free and maximal walking distances in IC,15–17  best evidence 18 
recommendations support the use of supervised exercise program (SEP).18,19 A recent 19 
Cochrane review update provided high-quality evidence that SEPs is more beneficial compared 20 
to placebo or usual care in improving both pain-free and maximum walking distance in people 21 
with symptomatic IC.20 22 
 Despite the level of evidence for the use of exercise therapy for the management of PAD and 23 
IC, and the professional bodies’ guidelines and endorsements, there are concerns that this is 24 
yet to be given a priority in the management of IC. 21,22 Access to, and uptake of health care is 25 
determined by factors within and outside the health care system.23,24 Some of the important 26 
stakeholders within this system are the patients, the healthcare professionals and the hospital 27 
management. To maximize patient outcomes related to exercise treatments for IC, the patients, 28 
health care professionals and facilities involved in IC treatment should align their management 29 
with best-evidence recommendations. However, little is known about the extent to which 30 
routine care treatments for IC align with best practice recommendation on exercise therapy.  31 
There is a close association between individuals’ attitudes and beliefs and their practices.25 It 32 
has been suggested that health care professionals’ self-interest and wider health system factors, 33 
but not lack of evidence, are among  the main challenges in adopting and implementing  34 
exercise recommendations for IC.21,26 This underscores the importance of understanding 35 
perceptions and practices related to routine provision of  exercise for IC. No systematic review 36 
has examined the attitudes, beliefs or practices of health care professionals, facilities or patients 37 
regarding exercise provision in routine care of IC.  38 
METHODS 39 
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Design and Rationale 1 
We performed a scoping review using five stages of the Arksey and  O’Malley scoping review 2 
methodology27 as revised by Levac et al.28 The completed review is reported according to the 3 
preferred reporting items for Systematic Reviews and Meta-Analysis extension for Scoping 4 
Reviews 29. A scoping review design was justified given that no prior systematic review 5 
evidence exists regarding the type and extent of available literature; and the need to 6 
systematically summarize primary research in an effective and timely manner. Findings will 7 
provide direction to reflect on ways to enhancing delivery of best practice exercise 8 
recommendations in the routine care of people with IC.   9 
Step 1: Identifying the research question 10 
The aim of this review is to scope literature on perceptions, practices, and workings of routine 11 
exercise programs for patients with IC, their availability, access and perceived barriers.  12 
Stage 2: Identifying relevant studies 13 
Search strategy:  14 
The search strategy was deliberately narrow and intended to retrieve only peer review 15 
published articles with a mention of exercise or exercise programs or walking or supervised 16 
exercise or homebased exercise or exercise therapy and peripheral vascular disease or 17 
intermittent claudication (and their synonymous terms) in their title, keywords, or abstracts. 18 
The search aimed to find only peer review published studies.  19 
Identification of primary research studies:  20 
A search was implemented in five databases (CINAHL via EBSCO, MEDLINE via 21 
ProQuest, AMED via Ovid, ScienceDirect, Social citation index/Science citation index 22 
/Emerging sources citation index via Web of Science (WOS)) and the Directory of Open 23 
Access Repositories website until February 2018 with no date parameters. The reference lists 24 
of included articles were checked for relevant studies. Search terms were identified by 25 
exploring the National Library of Medicine Subject Headings (MESH), in addition to exploring 26 
the keywords of relevant articles, and the search strategy was developed by the primary author 27 
(AU), with support of a co-author (DD). The following keywords were used: provision OR 28 
availability OR attitude OR perceptions OR perspective OR access OR accessibility AND 29 
exercise OR physical activity OR exercise training OR supervised exercise OR supervised 30 
exercise programs OR walking exercise OR walking program OR walking OR homebased 31 
exercise OR unsupervised exercise AND peripheral arterial disease OR peripheral vascular 32 
disease OR intermittent claudication OR intermittent claudication treatment. Abstract searches 33 
were performed for those words using Boolean operators, searching related terms and limited 34 
only to English language literature. An example of a detailed search strategy is shown in 35 
Appendix 1. 36 
 37 
Stage 3: Study Selection 38 
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Data management, screening and extraction:  1 
The identified studies were imported to Refworks™ and duplicates removed. Studies were then 2 
exported to Microsoft Excel 2010 where the screening were undertaken. Specific eligibility 3 
criteria were developed through iteration and piloting, and included the removal of studies that 4 
did not investigate exercise in routine care. Initially, titles and abstracts of identified studies 5 
were independently screened by two authors (UA, DD) and the overtly irrelevant studies were 6 
excluded. Next, the full text of selected studies after abstract and title screening were then read 7 
independently to determine studies inclusion in the review. Differences of opinion regarding 8 
inclusion or exclusion were resolved by discussion and reaching consensus between the two 9 
authors (UA, DD), or in consultation with a third author (CS) when consensus could not be 10 
reached. The process of identifying, screening, and inclusion of studies is summarized in Figure 11 
1. All articles had sufficient information enabling a decision on eligibility and inclusion; no 12 
study author was contacted to request missing information. 13 
Inclusion and exclusion criteria 14 
Articles meeting the following criteria were included in the review: 15 
Studies that focused on health care workforce directly or indirectly involved in exercise therapy 16 
for patients with IC (e.g. GPs, Surgeons, Physiotherapists, Nurses, Exercise physiologists) or 17 
focused on the description of routine delivery of exercise for individuals with PAD and IC 18 
(description could be reported by either health care professionals or patients).  Studies that 19 
reported on provision, attitude, access, availability or other factors regarding routine exercise 20 
for IC.  Studies of any design published in English and reported primary data whether they 21 
were published as full length article or only as abstract. No restriction was placed regarding 22 
publication date 23 
Stage 4: charting the data  24 
Critical appraisal: 25 
Given the review objective to scope the extent and type of literature, a quality appraisal was 26 
not implemented for this scoping review. This is consistent with current guideline for 27 
conducting systematic scoping reviews. 30 28 
Data collection and synthesis: 29 
Study characteristics were recorded in a data extraction form specifically developed and piloted 30 
for this review (Table 1). Data elements included authors’ details (author, year, and country), 31 
study aim, participant characteristics, study design, findings, and authors’ main conclusions. 32 
Studies meeting inclusion criteria were summarized in a narrative synthesis, including the 33 
overall number of studies, geographical location, design, population, and summary of results 34 
(Table 1). 35 
 36 
Stage 5: collating, summarising and reporting the results 37 
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A total of 102 records were identified through the searches. Following the screening process, 1 
8 records met the study inclusion criteria. The screening process and reasons for excluding 2 
studies is presented in Figure 1. Included studies are summarized in table 1. 3 
Characteristics of included studies 4 
The included studies were published between 2004 and 2017. All studies were from European 5 
countries. The Netherlands contributed the largest volume of literature (n=4), followed by the 6 
United Kingdom (n=2), and one study was from Germany (n=1). There was also one 7 
international study which surveyed respondents from 43 European countries (although it 8 
reported collected data from only 9 countries due to response variability)31.  9 
Populations 10 
Some studies had more than one population of interest. However, populations included 11 
vascular surgeons/vascular residents (n=4), patients and/or service user/delivery (n=3), and 12 
GPs and physiotherapists (n=1). 13 
Study design:  14 
According to the Littlewood and May classification32 all studies were primary research and 15 
were mostly of cross-sectional observational survey (n=5), followed by cohort studies (n=2), 16 
and a mixed-method study.  17 
Focus/theme of the studies:  18 
The included studies fell broadly into three categories: 19 
1) Determining access, availability, practice, provision, and opinion regarding exercise for 20 
IC. This include survey among vascular surgeons, vascular residents, physiotherapists, 21 
or patients (n=5). 22 
2) Investigating the role of GPs and physiotherapists in non-invasive therapy, including 23 
exercise therapy programs for people with IC (n=1) 24 
3) Documenting the functioning of routine exercise therapy programs s for IC and/or 25 
patients’ participation in the program (n=2) 26 
Outcomes in included studies 27 
 28 
Availability, Access and Practices related to Supervised exercise programs (SEPs): 29 
Three studies reported on the availability of SEPs and access to them, and scoped responses 30 
from vascular surgeons.31,33,34 Results showed that across Europe, less than 1 in 3 vascular 31 
surgeons reported having access to SEPs to refer patients.31 Country specific data  indicated 32 
that all vascular surgeons in the Netherlands, most (67%) of those in France, and about 10% in 33 
Spain and Greece have access to SEPs to refer their patients.31 Data from the UK suggest 34 
improvements in the access of vascular surgeons to SEPs over the past decade (24% in 2009, 35 
36% in 2012, and 41.6% in 2017), however the majority still did not have access to a SEP. 36 
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31,33,34 When examined in terms of facility access, just about one in three (38.9%) vascular units 1 
in the UK reported having access to SEP for UK NHS patients.34 2 
Between 2011 and 2012 about 45% of vascular surgeons within Europe who have access to 3 
SEP would refer less than 50% of their eligible patients, with only 18% saying they would refer 4 
all their patients.31 Almost half (46%) of UK vascular surgeons in 2009 reported referring less 5 
than 50% of their eligible patients for SEP, with only 14% referring 100% of their patients.33 6 
In a 2004 survey, although most (86%) GPs in the Netherlands indicated that they advised their 7 
patients with IC to exercise, 38% said they did not provide supervision or follow up as part of 8 
exercise therapy.35 Only a minority (15%) referred their patients to a physiotherapist for 9 
supervised exercise.35 Expectedly in this survey, only 8% of physiotherapists occasionally 10 
treated patients with IC.35 In a survey among patients a year later (Between 2005-2006), Dutch 11 
patients with IC reported that they received advice to walk mainly from their vascular surgeons 12 
and GPs, with only 11% reporting being referred to a physiotherapist for supervised exercise.36 13 
A survey in 2012, however, showed that almost all (about 97%) of vascular surgeons in the 14 
Netherlands reported referring more than 75% of their eligible patients for SEPs.37 15 
Only one study investigated if follow-up visits are schedule for patients who undergo SEP. 31 16 
In this survey, 70.4% of vascular surgeons said they will bring back patients for follow up. 17 
Similarly, one study reported that the majority of vascular surgeons would judge the success 18 
of SEP based on patients’ satisfaction, while improvement in walking distance were used by 19 
only 27% of the vascular surgeon.37   20 
Attitude to supervised exercise programs (SEPs) therapy: A study in Netherlands reported that 21 
all vascular surgeons surveyed agreed that SEP should be part of rehabilitation for IC, and that 22 
it is more effective than one-off unsupervised advice to walk (usual care).37 Also, a large 23 
majority of them (about 97%) agreed that SEP is the primary treatment for IC, believed that  24 
community-based and hospital-based SEPs are equally effective (about 93%), and 60% will 25 
consider continuing their patients in SEP beyond 3 months if patients do not show 26 
improvement.37  27 
Patient engagement and adherence to exercise therapy:  28 
A 2009-2010 investigation of routine exercise therapy for IC in a German outpatient clinic 29 
reported that 69% of the patients either declined invitation or did not eventually turn up for any 30 
of the training sessions.38 This study also indicated that only 22% of patients attended 31 
regularly.38 Similarly, a 2009 survey of vascular surgeons in the UK NHS showed that, where 32 
SEPs are available, majority of patients do not comply with recommendations: only 39% of 33 
them reported up to 50% patients of their patient taking SEP or adhering to their SEP 34 
recommendations.33 Although patients adherence to SEP had risen in 2017 (5 in 6 vascular 35 
units recorded >90% completion), patients engagement was still a great challenge (only 1 in 6 36 
of the vascular units had up to 80% of referred patients starting a SEP).34 These units did not 37 
generally document information related to commencement and completion rates for home-38 
based exercise therapy.34 39 
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A survey of Dutch patients with IC indicated that only 32% underwent SEP36. The majority 1 
(52%) walked for exercise  mostly in the neighborhood, and not reaching optimum walking 2 
intensity (only 44% walked through pain) or frequency (only 25% walked 3x/week).36 3 
Personnel who delivers exercise program: Vascular surgeons in the UK reported that exercise 4 
therapy for IC in the UK whether home or hospital based were run by physiotherapists and 5 
specialist nurses with a few run by exercise and non-healthcare professionals.33,34 Also vascular 6 
surgeons across Europe indicated that the majority (48%) of SEPs in their countries were run 7 
by physiotherapists while 37% were run by doctors.31 8 
Program types (Hospital versus Home based), and features of exercise programs: Regarding 9 
the site of exercise, one of the studies indicated that the majority of SEPs in the United 10 
Kingdom were delivered in hospital facilities.34 In contrast, the majority (70%) of Dutch 11 
patients with IC reported they received advice to walk at home.36 Hospital based SEPs in the 12 
UK generally consisted of either a combination of aerobic and resistance exercises or aerobic 13 
exercise alone.33,34. Whilst 55-90% of the programs lasted for 30-60 minute per session for 3 14 
months, 65-80% ran as one session per week (65-80%).33,34 Across Europe the  majority of 15 
SEP  programs were run as 1-2 hour/session (53%), and lasted between 3-6 months, but the 16 
number of sessions undertaken in a week was not investigated.31 17 
Common indications, contra-indications and obstacles to exercise:  18 
Vascular Surgeons’ attitude towards indications and contra-indications for people with IC for 19 
participation in SEPS was reported by two studies from Netherlands. The following 20 
comorbidities were cited as contraindications: mobility problems, hypertension, 21 
angina/IHD/ACS/MI, rest pain/tissue loss/CLI, musculoskeletal/arthritis,33 COPD/respiratory 22 
compromise,33,37 significant iliac stenosis,37 In contrast, maximal walking distance <100m or 23 
age >80 years were not considered contraindications. Also the majority of vascular surgeons 24 
would consider SEP as adjunct therapy pre- or post-surgery.37 Factors cited as obstacles to 25 
making SEP available to patients included resource challenge, and patient compliance.33 26 
Similarly reasons for not attending SEP in a German clinic included deficient patient 27 
motivation, travel distance, and the perception that exercise is physically demanding.38  28 
Alternative services in place when a SEP is not available or feasible 29 
The majority (75%) of patients in one study reported that they had received nonspecific advice 30 
to walk.36 Other reported alternatives included receiving specific instruction on how much walk 31 
that can be done (43%),31 and receiving verbal advice or leaflets (30%).31,33 32 
 33 
DISCUSSION 34 
The key aims of this systematic scoping review were to identify and map the body of literature 35 
related to routine provision of exercise for the treatment IC. Findings provide an essential 36 
contribution for reflections and research on access, utilization and stakeholders’ perspectives 37 
on the guideline-recommended, non-invasive therapy for this patient population. It was 38 
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deliberate to include only studies that reported on exercise in routine care, and excluded the 1 
vast majority of studies because they reported on trials and/or experimental studies of exercise 2 
interventions. The inclusion of only eight eligible studies underscores the paucity of literature 3 
on this topic. The overall trend showed that literature related to provision of exercise in routine 4 
care for persons with PAD and IC is relatively new (<14years old), and nonexistent in majority 5 
of countries in Europe and around the world.  6 
Similarly, the overall volume of literature remained small despite the overwhelming evidence 7 
of the benefits and effectiveness of exercise therapy in experimental literature. Furthermore, 8 
the geographical location of studies highlights that larger area of the global health systems is 9 
not yet represented. For instance, the majority of the publications were from the Netherlands 10 
and United Kingdom, and no data was found originating from outside Europe. This may 11 
indicate that despite the fact that much research evidence supporting exercise as a treatment for 12 
IC is relatively old, research into practices related to routine provision of exercises in health 13 
care systems is yet to be made a research priority. Paucity of research into provision of exercise 14 
in the management of IC may also reflect the absence of this service in most public health 15 
systems around the world. For instance the Centers for Medicare and Medicaid Services (CMS) 16 
in the US only gave a national coverage decision (NCD) of supervised exercise therapy for 17 
PAD and IC in mid-2017.39 Until this decision, there was no  national coverage reimbursement 18 
for supervised exercise therapy treatment for patients with PAD and IC.  19 
Although vascular surgeons in parts of Europe generally recognize SEPs to be beneficial to 20 
patients with PAD and IC, they do not often refer their patients for SEPs due to the 21 
unavailability of programs or lack of access. Where programs are available and accessible, 22 
challenges related to patients’ engagement and adherence were significant causes of sub-23 
optimal implementation, and may be some of the reasons why about 45% of surgeons within 24 
Europe refer less than 50% of their eligible patients to SEP.31 Another important concern is 25 
that routine SEPs may not be complying with the best practice recommendations in terms of 26 
frequency. For instance, the frequency of the sessions for the greater majority of SEPs in the 27 
UK is once a week,33,34 and this arguably raises a question about the efficacy of the programs. 28 
The included studies in this review did not research on why the hospitals are only putting on 29 
the sessions once per week. However, there is an opinion that the commissioners in the UK 30 
NHS are reluctant to fund SEPs and best medical therapy in majority of patients with IC. 31 
Certainly, this highlights the need to adequately incentivize and reward hospitals to prioritise 32 
supervised exercise and best medical therapy as a first option prior to surgical intervention.21 33 
Similarly, barriers to exercise in patients with PAD and IC are multidimensional including 34 
individual level factors (e.g. poor health literacy and comorbid health concerns), disease 35 
specific factors (e.g. claudication pain), and availability or otherwise of environmental and 36 
social enablers,40,41 and worth considering when planning exercise for patients. 37 
Despite seeing no improvement in the walking distances of patients at 12 weeks, 60% of 38 
providers considered continuing SEPs.  Some patients specific factors may require a longer 39 
duration than 12 weeks for important benefits to be accrued. In addition, there is evidence of 40 
benefits to overall cardiovascular health and quality of life of exercise in patients with PAD 41 
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and IC, separate from any improvement in walking ability measures.42 Indeed, it is the potential 1 
improvement in cardiovascular health and the overall potential secondary prevention benefits 2 
that is central to exercise therapy recommendations in patients with PAD and IC.42,43 Therefore, 3 
considering continuing SEPs in absence of improvement in walking distances is 4 
recommended.39   5 
Some limitation regarding the review findings need to be considered. First, although our search 6 
string aimed to include data from all regions of the world, it was limited to peer review 7 
published English language literature. Literature in other languages may not have been 8 
retrieved, and retrieved data were limited to a few countries within Europe. Second, poor 9 
response rates in the surveys of vascular surgeon in the UK (24.6%), and in Europe (23%) 10 
meant that caution should be applied when generalizing finding to all the UK or Europe.  11 
 12 
Conclusion 13 
A number of conclusions can be drawn. SEPs are not always utilized by referring healthcare 14 
providers. Although health professionals recognize that SEPs are useful and should be available 15 
and accessible to patients with IC, available evidence indicates that SEPs are not always 16 
available or accessible to patients. When available, the sustainability of continual provision of 17 
SEPs in the continuum of chronic disease pathway of IC may not be feasible due to the resource 18 
and time cost to both the patient and the health system. Key areas of focus for integrating and 19 
implementing exercise recommendations to routine clinical practice in people with IC are 20 
needed. It may be important to understand factors such as barriers and enablers to exercise in 21 
individuals with PAD and IC. Although some may be similar across health systems, many may 22 
be specific to each health system and need to be investigated individually. It will be beneficial 23 
to understand why health systems do not fund SEPs for PAD and IC despite the overwhelming 24 
evidence for the clinical and cost effectiveness. This may be important to further understanding 25 
of patient, environmental and behavioral constructs worth considering in developing relevant 26 
and patient-focused intervention to increase the availability of and access to exercise programs, 27 
as well as to encourage the uptake and adherence to exercise in people with PAD and IC.  28 
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